An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice (ACT-SOLO)

Condition:   Rheumatoid ArthritisIntervention:   Sponsor:   Hoffmann-La RocheCompleted - verified June 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials